We are live on ! Find out more
Millennium Management

Millennium Management Portfolio holdings

AUM $276B Turnover 27.44%
1-Year Est. Return 44.8%
 

Millennium Management is a multistrategy hedge fund firm, started in 1989 by Israel Englander along with Ronald Shear, an acquaintance from the American Stock Exchange who left after six months. Englander remains its principal. It works as a platform: many separate investment teams, each with a portfolio manager given money to trade in a variety of strategies. Its teams research and pick individual companies, run computer-driven strategies, and trade fixed income, commodities and credit. In 2018 it launched a joint venture with WorldQuant, a computer-driven investment firm. Its clients include state and local government bodies and sovereign wealth funds.

This Fund
S&P 500
This Quarter Est. Return
+19.61%
1 Year Est. Return
+44.8%
3 Year Est. Return
+127.22%
5 Year Est. Return
+155.52%
10 Year Est. Return
+768.06%
AUM
$276B
AUM Growth
+$36B
Cap. Flow
-$4.1B
Cap. Flow %
-1.48%
Top 10 Hldgs %
18.44%
Holding
6,628
New
986
Increased
2,006
Reduced
2,341
Closed
833
Avg Time Held Equity + Options
2.9 years
Top 10 Avg Time Held Equity + Options
2.5 years
Top 20 Avg Time Held Equity + Options
3 years
Avg Time Held Equity only
3.1 years
Top 10 Avg Time Held Equity only
1.1 years
Top 20 Avg Time Held Equity only
1 year

Sector Composition

Rank Sector Weight
1 Miscellaneous 55.34%
2 Technology 9.51%
3 Industrials 7.56%
4 Financials 5.78%
5 Healthcare 5.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
LFTO icon
2251
Liftoff Mobile
LFTO
$2.66B
$9.49M ﹤0.01%
+395,147
New +$10.2M
2026 Q2
0 quarters
TECH icon
2252
CALL
Bio-Techne
TECH
$11.4B
$9.47M ﹤0.01%
+134,100
New +$7.24M
2026 Q2
0 quarters
LAC icon
2253
Lithium Americas
LAC
$708M
$9.47M ﹤0.01%
2,460,382
+1,396,873
+131% +$6.65M
2024 Q2
8 quarters
MEVO icon
2254
M Evo Global Acquisition Corp II
MEVO
$9.47M ﹤0.01%
+954,475
New +$9.46M
2026 Q2
0 quarters
IRD icon
2255
Opus Genetics
IRD
$355M
$9.46M ﹤0.01%
2,302,101
-328,331
-12% -$1.53M
2025 Q4
2 quarters
BY icon
2256
Byline Bancorp
BY
$1.74B
$9.44M ﹤0.01%
250,593
-37,071
-13% -$1.25M
2025 Q1
5 quarters
QLEP
2257
Quantum Leap Acquisition Corp
QLEP
$302M
$9.43M ﹤0.01%
+950,000
New +$9.44M
2026 Q2
0 quarters
FBK icon
2258
FB Financial Corp
FBK
$2.75B
$9.43M ﹤0.01%
170,331
+110,674
+186% +$5.94M
2021 Q4
18 quarters
GH icon
2259
CALL
Guardant Health
GH
$22.6B
$9.41M ﹤0.01%
62,700
-32,500
-34% -$3.53M
2025 Q1
5 quarters
OUT icon
2260
Outfront Media
OUT
$5.72B
$9.4M ﹤0.01%
286,815
+221,270
+338% +$6.87M
2025 Q2
4 quarters
ENTA icon
2261
Enanta Pharmaceuticals
ENTA
$310M
$9.39M ﹤0.01%
643,967
-238,130
-27% -$3.2M
2018 Q4
30 quarters
INCY icon
2262
Incyte
INCY
$25B
$9.39M ﹤0.01%
82,812
-90,103
-52% -$8.94M
2017 Q3
35 quarters
GD icon
2263
CALL
General Dynamics
GD
$98.6B
$9.39M ﹤0.01%
26,500
-500
-2% -$171K
2020 Q1
25 quarters
ENTG icon
2264
Entegris
ENTG
$21.8B
$9.36M ﹤0.01%
52,054
+41,052
+373% +$5.92M
2024 Q3
7 quarters
BBD icon
2265
Banco Bradesco
BBD
$28.7B
$9.36M ﹤0.01%
2,696,897
+1,624,682
+152% +$5.95M
2015 Q2
44 quarters
MTG icon
2266
MGIC Investment
MTG
$5.98B
$9.36M ﹤0.01%
331,836
+53,366
+19% +$1.42M
2013 Q2
52 quarters
ANDE icon
2267
Andersons Inc
ANDE
$1.88B
$9.35M ﹤0.01%
136,739
-1,029
-0.7% -$74.8K
2024 Q3
7 quarters
CYTK icon
2268
Cytokinetics
CYTK
$8.84B
$9.35M ﹤0.01%
109,717
+11,758
+12% +$844K
2024 Q3
7 quarters
SBET icon
2269
Sharplink Inc
SBET
$1.55B
$9.34M ﹤0.01%
1,946,094
-4,435,579
-70% -$28.4M
2025 Q2
4 quarters
ATAI icon
2270
DELISTED
AtaiBeckley Inc
ATAI
$9.33M ﹤0.01%
1,770,526
-2,593,570
-59% -$10.9M
2026 Q1
1 quarter
NPK icon
2271
National Presto Industries
NPK
$1.07B
$9.33M ﹤0.01%
74,636
+36,355
+95% +$4.93M
2025 Q3
3 quarters
SKM icon
2272
SK Telecom
SKM
$12B
$9.31M ﹤0.01%
289,624
-1,064,824
-79% -$39.4M
2022 Q1
17 quarters
SBAC icon
2273
CALL
SBA Communications
SBAC
$20.7B
$9.3M ﹤0.01%
+52,700
New +$10.9M
2026 Q2
0 quarters
CI icon
2274
CALL
Cigna
CI
$80.7B
$9.29M ﹤0.01%
33,700
-7,200
-18% -$2.03M
2021 Q1
21 quarters
ANL icon
2275
Adlai Nortye Group ADS
ANL
$619M
$9.29M ﹤0.01%
807,832
+126,057
+18% +$1.53M
2026 Q1
1 quarter

Similar funds

Millennium Management's Q2 2026 Portfolio in Review

As of Q2 2026, Millennium Management held 6,628 positions worth $276B, up 15% from $240B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Millennium Management's Q2 2026 filing shows 986 new, 2,006 increased, 2,341 reduced and 833 closed positions. Its largest new stake was SpaceX: 17,604,863 shares worth $2.98B. The largest sale was State Street SPDR Portfolio S&P 500 ETF, an estimated $1.65B.

By sector, the portfolio is most concentrated in Miscellaneous at 55% of assets, up from 54% a quarter earlier, followed by Technology and Industrials.

  • Millennium Management's largest Q2 2026 buy was SpaceX: 17,604,863 shares worth $2.98B.
  • Millennium Management added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $3.07B increase.
  • Millennium Management's biggest Q2 2026 reduction was Marvell Technology, cutting an estimated $1.16B.
  • Millennium Management fully exited State Street SPDR Portfolio S&P 500 ETF in Q2 2026, selling an estimated $1.65B.
  • Millennium Management's ten largest holdings make up 18% of its $276B portfolio in Q2 2026.
  • Millennium Management opened 986 new positions and closed 833 in Q2 2026.
  • Millennium Management's portfolio value rose 15% quarter-over-quarter to $276B.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.